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Hydroxymethylcytosine, well described in DNA, occurs also in RNA. Here, we show that
hydroxymethylcytosine preferentially marks polyadenylated RNAs and is deposited by Tet in
Drosophila.We map the transcriptome-wide hydroxymethylation landscape, revealing
hydroxymethylcytosine in the transcripts ofmany genes, notably in coding sequences, and identify
consensus sites for hydroxymethylation.We found that RNA hydroxymethylation can favor mRNA
translation.Tet and hydroxymethylated RNA are found to be most abundant in the Drosophila
brain, and Tet-deficient fruitflies suffer impaired brain development, accompanied by decreased
RNA hydroxymethylation.This study highlights the distribution, localization, and function of
cytosine hydroxymethylation and identifies central roles for this modification in Drosophila.
I
n DNA, vertebrate Tet methyldioxygenases
(Tet1, Tet2, and Tet3) catalyze hydroxylation
of 5-methylcytosine to 5-hydroxymethylcytosine
(1–3). Tet also catalyzes the formation of hy-
droxymethylcytosine in RNA (referred to here
as hmrC) (4, 5). To date, however, the distribution,
localization, and functional relevance of hmrC re-
main unknown.
In the present study, we have sought to pro-
vide a better understanding of hmrC. For ease of
interpreting results, we analyzed hmrC in Dro-
sophila melanogaster because (i) cytosine meth-
ylation inDrosophilaDNA is either absent or very
low, being restricted to specific cellular contexts
(6, 7), and (ii) we have found no evidence of DNA
hydroxymethylation in this organism (fig. S1). To
detect 5hmCRNAmodification,weusedanantibody
raised against 5-hydroxymethylcytosine (8, 9). To
confirm that it will bind to hmrC, we performed
dot blot experiments using in vitro transcribed
templates containing either unmethylated, methy-
lated, or hydroxymethylated cytosines (table S1).
The antibody to 5hmC specifically detected 5hmC-
containing RNA. In addition, detection of 5hmC
was abolished after ribonuclease (RNase) A treat-
ment (fig. S2A).
We detected hmrC in dot blot experiments on
total RNA extracted fromDrosophila S2 cells (Fig. 1A
and fig. S2, B and C). Isolation of polyadenylated
RNA from S2 cells followed by immunoblotting
showed strong enrichment in hmrC signal as
compared with that of total cellular RNA (Fig.
1B and fig. S2, D and E). No signal was de-
tected in fractions enriched in small RNAs or
ribosomal RNAs (Fig. 1C and fig. S3, A and B).
Drosophila possesses only one conserved Tet
ortholog, CG43444 (dTet) (10, 11). Depletion of
dTet in S2 cells, by using RNA interference for
dTet (dTet KD), revealed a 54% decrease in dTet
transcripts, as compared with control cells (Fig.
1D). Dot blotting with antibody to 5hmC showed
a similar decrease in hmrC—44%—upon dTet
knockdown (Fig. 1D and fig. S3, C and D).
To map the hmrC modification landscape in
a transcriptome-wide manner, we adapted a re-
cently used method [methylated RNA immuno-
precipitation followed by sequencing (MeRIP-seq)]
(12, 13), which we call hMeRIP-seq. This method
involves immunoprecipitation of hmrC-containing
RNA with the antibody to 5hmC followed by next-
generation sequencing. hMeRIP-seq in S2 cells
yielded 3058 significantly enriched regions (“hmrC
peaks,” P < 10−10) within 1597 coding gene tran-
scripts (fig. S4, A to C, and table S2). Examples
of enrichment profiles are shown in Fig. 2A.
Several key controls were performed so as to en-
sure the validity and stringency of our experimental
approach: (i) Further bioinformatic analyses dem-
onstrated that our hMeRIP-seq experiments did
not merely coprecipitate abundant RNA fragments
282 15 JANUARY 2016 • VOL 351 ISSUE 6270 sciencemag.org SCIENCE
1Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB
Cancer Research Center (U-CRC), Université Libre de
Bruxelles (ULB), Brussels, Belgium. 2Waksman Institute,
Department of Molecular Biology and Biochemistry, Cancer
Institute of New Jersey, Rutgers University, Piscataway, NJ,
USA. 3Laboratory of Molecular Biology of the Gene, Faculty
of Sciences, Université Libre de Bruxelles, Gosselies,
Belgium. 4Institut für Molekularbiologie und Tumorforschung,
Philipps-Universität Marburg, Marburg, Germany.
5Department of Chemistry, University of Cincinnati,
Cincinnati, OH, USA.
*These authors contributed equally to this work. †Present address:
Division of Signaling and Gene Expression, La Jolla Institute for
Allergy and Immunology, La Jolla, CA 92037, USA. ‡Present
address: Section of Molecular Biology, University of California, San
Diego, La Jolla, CA 92093, USA. §Present address: Department of
Cancer Biology, University of Cincinnati, Cincinnati, OH, USA.
||Present address: Roche Diagnostics, 68305 Mannheim, Germany.
¶Present address: Robert Wood Johnson Medical School, Depart-
ment of Medicine, Rutgers University, Piscataway, NJ, USA.


































































































Fig. 1. RNA hydroxymethylation by dTet in Drosophila S2 cells. (A) Dot
blotting on total RNA from Drosophila S2 cells with antibody to 5hmC, treated
or not with RNase A (serially halved amounts of RNA, starting at 1 mg). Data
are mean ± SD (n = 4 experiments run) with a representative blot shown.
(B) Immunoblotting with anti-5hmC antibody was performed on polyadenyl-
ated and total RNA from S2 cells. Data are mean ± SD (n = 3 experiments
run). (C) hmrC content of total RNA as well as fractions enriched in small
RNA or rRNA was assessed by dot blotting. Data are mean ± SD (n = 3
experiments run). A vertical line indicates juxtaposition of lanes within the
same blot, exposed for the same time. (D) dTet knockdown leads to reduced
hmrC levels. (Left) Quantitative RT-PCR analysis. (Right) Dot blotting. Data
are mean ± SD (n = 4 experiments run).
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nonspecifically (Fig. 2B and fig. S5); (ii) up to
79.4% of hmrC sites showed significant reduction
levels in hMeRIP-seq upon dTet depletion as
compared with that of control S2 cells, with 85.5%
of the sites showing a more than fourfold reduc-
tion in hmrC levels (Fig. 2C and fig. S6); and (iii)
replicate hMeRIP-seq experiments by using an
additional antibody to 5hmCshowed strong agree-
ment between experiments performed with the
two 5hmC antibodies (fig. S7 and table S3).
The distribution of hmrC peaks revealed by
hMeRIP-seq analyseswas significantly nonrandom
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Fig. 2. Transcriptome-wide distribution of hmrC in Drosophila cells. (A) Representative UCSC
Genome Browser plot from hMeRIP-seq data. (B) Distribution of all expressed (gray) or hmrC-
enriched (green) transcripts, showing the number of mRNAs as a function of their expression levels.
In hMeRIP-seq, enrichment in both abundant and less abundant fragments was observed. (C) hMeRIP-
seq in cells depleted of dTet shows reduced hmrC levels at the majority of target regions. (Left) Box plot
of the normalized number of hmrC reads in dTet-depleted cells versus control cells. (Center) Pie chart
showing the percentage of reduced hmrC peaks, with (right) a more than fourfold reduction at most
targets. (D) Distribution of hmrC peaks according to the type of structural element within the transcript. *P < 10−5). (E) Sequence motif identified within
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Fig. 3. RNA hydroxymethylation can favormRNA translation. (A) Sucrose gradient fractionation followed bydot-blot quantification shows that active translation
is associated with a high hmrC content. Data are mean ± SD (n = 3 experiments run). (B) In vitro translation of C-, mC-, and hmC-containing RNAs, as measured by
incorporation of 35S-radiolabeledmethionine, shows thatmethylation decreases translation and hydroxymethylation restores it. Shown are the normalized scintillation
counts (top) and the results of SDS–polyacrylamide gel electrophoresis (SDS-PAGE) followed by fluorography (bottom). Data aremean ±SD (n= 3 experiments run).
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(P < 10–5), with many of these peaks found in
coding sequences (48%) (Fig. 2D). Further analyses
identified an overrepresented motif with oc-
currences in a large proportion of peaks (64%)
and which tends to be highly UC-rich, contain-
ing UCCUC repeats (Fig. 2E and fig. S8A). Gene
Ontology analysis of the hmrC targets showed
enrichment for genes involved in basic cellular
processes and notably in the regulation of em-
bryogenesis and development (fig. S8B and table
S6). In addition, exons were more enriched in
hmrC than introns (fig. S9D). Thus, the above
data present the hmrC-enriched transcriptome,
revealing the presence of this modification in
specific mRNA regions and in specific sequence
contexts.
Next, we knocked down dTet expression in S2
cells and performed RNA-sequencing (RNA-seq)
experiments in order to assess how many mRNAs
might be regulated by dTet. We found the expres-
sion of 574 mRNAs to change after dTet depletion
(50.4% were more abundant, whereas 49.6%
were less abundant) (Fig. 2F; fig. S9, A to C; and
table S4). Examples of mRNAs whose levels either
increased or decreased upon dTet knockdown are
shown in fig. S9, A and B. A positive correlation
was observed between transcript abundance and
the presence of hmrC peaks (Fig. 2B and fig. S5).
We then compared these dTet-regulated mRNAs
with the targets identified by hMeRIP-seq and
found a slight but significant percentage (26%,
P < 10−43) of the dTet-regulated mRNAs to con-
tain at least one hmrC peak (Fig. 2G, figs. S9C
and S11, and table S5). It is worth mentioning
that dTet contains an N-terminal CXXC Zn-finger
domain, which likely explains the reported ability
of mammalian Tets to regulate gene expression
independently of their catalytic activity (14, 15).
It thus remains possible that dTet might affect
gene expression via its CXXC domain, indepen-
dently of its ability to hydroxylate methylated
RNA (fig. S10, A and B). This domain, however,
is likely not required for the role of dTet in
Drosophila brain development (see below) be-
cause flies where dTet CXXC is deleted are still
viable and show no specific phenotype (11).
To examine how cytosine hydroxymethylation
might affect mRNA function, we examined the
distribution of hmrC as a function of the mRNA
translational status in Drosophila S2 cells. For
this, we performed standard sucrose-gradient frac-
tionation followed by dot blotting. A correlation
betweenhmrCabundance andactivemRNA trans-
lation was observed; fractions with low translation
activity (freemRNAs andmonosomes) were found
to be poor in hmrC, whereas mRNAs heavily
loaded with ribosomes (polysome fractions)
showed a high hmrC content (Fig. 3A). We also
assessed how mrC distributes across polysome
fractions and found it to be high inmonosomes
and low in polysomes (fig. S12). Next, we examined
whether mRNA hydroxymethylation might af-
fect mRNA translation. In vitro translation of
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Fig. 4. dTet-deficient fruitflies show impaired brain development, ac-
companied by decreased RNA hydroxymethylation. (A) dTet expression
and hmrC levels during Drosophila embryogenesis. Data are mean ± SD (n =
4 experiments run). (B) (Left) Pattern of endogenous GFP-tagged dTet in the
larval brain. Scale bar, 50 mm. (Center) Scheme of the larval brain. (Right)
Confocal brain section showing the expression of endogenous dTet (green) and
F-actin (red). DNA, blue. Scale bar, 10 mm. (C) (Top) dTet expression in the
salivary gland, brain, and ovary. Data are mean ± SD (n = 3 experiments run).
(Bottom) Immunoblotting with 5hmC antibody in RNA from salivary gland,
brain, and ovary. Vertical line indicates juxtaposition of lanes within the same
blot, exposed for the same time. (D) (Left) dTetnull brains are smaller than
wild-type brains. Dpn (neuroblasts), green; F-actin, red; DNA, blue. Scale bar,
50 mm. (Right) Average width of the medulla region containing the neuro-
blasts (left, red arrow). Error bars represent 95% confidence intervals (p < 2.4
10−9) for 20 brain lobes. (E) Brains of dTet-deficient larvae show a decrease
in hmrC. Data are mean ± SD (n = 3 experiments run).
RESEARCH | REPORTS
unmodified, methylated, and hydroxymethyl-
ated Firefly Luciferase–encoding RNA templates
in rabbit reticulocyte lysate showed a decrease
in translation of methylated RNAs. In contrast,
hmrC-modified templates gave rise to near-control
protein levels (Fig. 3B), suggesting that hydroxy-
methylation can restore the translation efficiency
of previously methylated substrates.
We next sought to assess hmrC in vivo in fruit-
flies. To determine the timing of dTet expression
andof the appearanceofhmrCduring early embryo-
genesis of D. melanogaster, we performed quantita-
tive reverse transcriptionpolymerase chain reaction
(RT-PCR) to measure dTet transcript levels, and
immunoblotting to estimate levels of hmrC. We
found that dTet levels correlate positively with
hmrC levels during fruitfly embryogenesis (Fig. 4A
and fig. S13A).Wealso analyzed apublicly available
database of RNA-seq results from different stages
of D. melanogaster development and found that
in third-instar larvae, dTet expression is highest in
the central nervous system (fig. S13B). These findings
suggest that dTet-mediated hydroxymethylation
of RNA could play a role in the fruitfly brain. To
confirmandextend these observations,wegenerated
transgenic Drosophila flies expressing a GFP-dTet
fusion construct under the control of the endog-
enous dTet promoter (called dTet-Mi). The green
fluorescent protein (GFP)–tagged dTet protein was
detected throughout the larval brain, the highest
levels being detected in the optic lobe and central
brain (Fig. 4B).
It was of interest to assess whether the fly brain
contains high levels of hmrC. To this end, in ad-
dition to the brain, we used ovary [because this
was the organ chosen to show the role of dTet in
DNA m6A demethylation (11)]. We also used an-
other organ, the salivary gland, from which we
could extract enough RNA to measure hmrC levels.
Quantitative RT-PCR and dot blotting showed
higher dTet expression and hmrC content in
the brain than in the ovary or in the salivary gland
of the fruitfly (Fig. 4C). Hence, by revealing that
the hmrC signal is highest in the brain, these
data support the argument for the importance
of hmrC in this organ.
We wished to evaluate RNA hydroxymethyl-
ation levels in a complete loss-of-function mu-
tant of dTet (fig. S13, C and D). In agreement
with recent observations (11), dTet-deficient ani-
mals survived through the larval stages but died
at the pupal stage (no adult animals survived;
n > 5000 dTet-null animals analyzed) (fig. S13E).
Morphological defects were observed at larval
stages: The brains of mutant larvae were smaller
than those of normal larvae and showed abnor-
mal organization of neuroblasts in their central
part (Fig. 4D). To quantify the observed changes,
we measured the width of the medulla region
(based on 20 examined brains). We found it to
be significantly reduced in dTetnull animals (P <
2.4 × 10−9), likely reflecting a lower number of
neuroblasts (Fig. 4D). To measure the effects of
dTet loss on the RNA hydroxymethylation level,
we performed immunoblotting analyses with
antibody to 5hmC on brains from dTetnull and
wild-type larvae. These experiments showed a
decreased hmrC content in the brains of dTet-
deficient larvae (Fig. 4E and fig. S14).
Our understanding of the posttranscriptional
modifications that decorate RNA, a regulatory
layer positioned betweenDNA and proteins, is in
its infancy.We have conducted a study addressing
the distribution, localization, and function of cy-
tosine hydroxymethylation in RNA, using Dro-
sophila melanogaster as a model. Our work has
yielded the following key findings: (i) It provides
a picture of the hydroxymethylated transcriptome,
(ii) reveals an unrecognized function for hmrC,
and (iii) suggests a central role for this RNAmodif-
ication and dTet in the Drosophila brain. All in
all, we expect this study to change the way we
think about the roles played by cytosine hydroxy-
methylation and the Tet proteins. Our findings
open new research prospects in an emerging
realm of biological regulation: epitranscriptomics.
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GENE REGULATION
Transcription factors LRF and BCL11A
independently repress expression of
fetal hemoglobin
Takeshi Masuda,1 Xin Wang,2 Manami Maeda,1 Matthew C. Canver,3 Falak Sher,3
Alister P. W. Funnell,4 Chris Fisher,5 Maria Suciu,5 Gabriella E. Martyn,4
Laura J. Norton,4 Catherine Zhu,1 Ryo Kurita,6 Yukio Nakamura,6,7 Jian Xu,3,8
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Genes encoding human b-type globin undergo a developmental switch from embryonic to
fetal to adult-type expression. Mutations in the adult form cause inherited
hemoglobinopathies or globin disorders, including sickle cell disease and thalassemia.
Some experimental results have suggested that these diseases could be treated by
induction of fetal-type hemoglobin (HbF). However, the mechanisms that repress HbF in
adults remain unclear. We found that the LRF/ZBTB7A transcription factor occupies fetal
g-globin genes and maintains the nucleosome density necessary for g-globin gene silencing
in adults, and that LRF confers its repressive activity through a NuRD repressor complex
independent of the fetal globin repressor BCL11A. Our study may provide additional
opportunities for therapeutic targeting in the treatment of hemoglobinopathies.
D
uring human development, the site of eryth-
ropoiesis changes from the embryonic yolk
sac to the fetal liver and then, in newborns,
to the bonemarrow, where it persists through
adulthood. Coincidentally, there is a “globin
switch” from embryonic to fetal globin genes in
utero, and then a second switch from fetal to
adult globin expression soon after birth. This pro-
cess has been studied for more than 60 years
(1). The latter transition from fetal to adult
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